THE WESTERN NEW YORK SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Presents

Infectious Diseases Symposium

SPEAKERS:

John Sellick, DO, MS
Associate Professor of Medicine
Division of Infectious Diseases
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo, State University of New York

Magdalena Wrzesinski, PharmD
PGY-2 Infectious Diseases Resident
Buffalo General Medical Center

Holly Murphy, PharmD, AAHIVP, BCPS
Clinical HIV/AIDS Pharmacotherapy Specialist
Erie County Medical Center

Kari Mergenhagen, PharmD, AQ-ID, BCPS
Clinical Infectious Diseases Pharmacy Specialist
Veterans Affairs Wester New York Healthcare System

LOCATION: Millennium Hotel
2040 Walden Ave
Buffalo, NY 14225

DATE: Saturday, March 24th

OBJECTIVES: See page 3 and 4

AUDIENCE: Intended for Health-system pharmacists, students, technicians, faculty and pharmaceutical representatives

PROGRAM TYPE: Knowledge-based

PROGRAM: 7:30AM – 8:00AM Registration/Breakfast Buffet/Vendor Displays
8:00AM – 8:50AM Speaker 1
8:50AM – 9:40AM Speaker 2
9:40AM – 9:50AM Student Clinical Pearl
9:50AM – 10:00AM Break
10:00AM – 10:50AM Speaker 3
10:50AM – 11:50AM Speaker 4

RESERVATIONS: Please confirm your reservations by Friday, March 16th by registering on line

Indicate your dinner selection:
Breakfast buffet

COST AND REFUND POLICY:
1. Registration Fee: Members $30, Pharmacy Residents $20, Students $20, Non-Member Students $35, Technicians $15, Non-Member Technicians $30, PAWNY/ASCP MEMBERS $40, Non Members $100. Payment is due on the meeting date.
2. Please make checks payable to: WNYSHP
3. Cancellations MUST BE RECEIVED BY March 16, 2018 otherwise the registrant will be required to pay a $15 cancellation fee. Pre-payments will be refunded if cancellation received by this date.
4. LATE REGISTRATION FEE IS $5 for registrations after March 16, 2018

CONTINUING EDUCATION CREDITS:
The NYSCHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. This program is approved for 0.4 CEU's (4 contact hours). Statements of Continuing Pharmacy Education Credit are available to participants upon the conclusion of the program with a survey link. Participant must verify attendance at the meeting by entering the program CE code.

Attendees have 45 days from the date of the program to retrieve their credits. Payments to NYSCHP or WNYSHP are not deductible as charitable contributions for federal income tax purposes. However, they may be deductible under other provisions of the Internal Revenue Code (i.e., ordinary, necessary business expenses; miscellaneous itemized deduction).

Learning Objectives for Pharmacists and Technicians:

John Sellick, DO, MS
Tick Borne Diseases
Learning Objectives (pharmacists & technicians):
1. Understand the Importance of Tick Borne Diseases (TBD) in the US
2. Understand the basic biology and life cycle of ticks
3. Recognize the common and variable presentations of TBD
4. Understand the pitfalls in laboratory diagnosis of TBD
5. Recognize the indications for use of oral and parenteral antimicrobial therapy for non–viral TBD

Magdalena Wrzesinski, PharmD
New Drugs for Bad Bugs: Overcoming the Challenges of Antimicrobial Resistance
Learning Objectives (pharmacists):
1. Describe treatment approaches for infections caused by multi-drug resistant organisms
2. Compare and contrast newly approved antibiotics and their emerging places in therapy
3. Discuss the utilization of older antibiotics in the setting of growing resistance
4. Identify antibiotics in the FDA pipeline and their potential places in therapy

Learning Objectives (technicians):
1. Describe the epidemiology of multi-drug resistant infections
2. Describe the clinical implications of multi-drug resistant infections
3. Identify multi-drug resistant bacteria requiring new antibiotics
4. Identify newly approved antibiotics for multi-drug resistant organisms

Holly Murphy, PharmD, AAHIVP, BCPS
C The Cure – Current Therapies in Treating Hepatitis C
Learning Objectives (pharmacists):
1. Discuss the epidemiology and risk factors associated with Hepatitis C (HCV)
2. Review the pathophysiology and progression of HCV
3. Describe current guideline-based treatment strategies for treating HCV
4. Identify benefits and drawbacks of emerging and current HCV therapies
5. Recognize common drug-drug interactions associated with HCV direct acting-antivirals
6. List patient barriers to successful HCV treatment

Learning Objectives (technicians):
1. Describe the difference between HCV and other types of hepatitis
2. Identify common medications used to treat HCV
3. List patient barriers to successful HCV treatment
4. Understand ways that pharmacists and pharmacy technicians can improve adherence to HCV therapy

Kari Mergenhagen, PharmD, AQ-ID, BCPS
Penicillin Skin Testing and Desensitization
Learning Objectives (pharmacists):
1. Describe the implications of penicillin allergy on the treatment of patients with infectious diseases
2. Describe the role of penicillin skin testing in the inpatient and outpatient setting
3. Describe the role of penicillin skin testing versus desensitization as it relates to antimicrobial stewardship
4. Review literature to determine the effectiveness of penicillin skin testing and desensitization
5. Develop a penicillin skin testing service and tools for desensitization for your institution

Learning Objectives (technicians):
1. Describe the importance of penicillin skin testing
2. Describe how penicillin skin testing is a useful component of an antimicrobial stewardship program
3. Describe what penicillin skin testing consists of
4. Describe the components needed for penicillin skin testing